论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
蛋白酶体(Proteasome),有望成为癌症以外多种疾病的治疗目标
Authors Cao Y, Zhu H, He R, Kong L, Shao J, Zhuang R, Xi J, Zhang J
Received 16 June 2020
Accepted for publication 22 September 2020
Published 19 October 2020 Volume 2020:14 Pages 4327—4342
DOI https://doi.org/10.2147/DDDT.S265793
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Jianbo Sun
Abstract : Proteasome is vital for intracellular protein homeostasis as it eliminates misfolded and damaged protein. Inhibition of proteasome has been validated as a powerful strategy for anti-cancer therapy, and several drugs have been approved for treatment of multiple myeloma. Recent studies indicate that proteasome has potent therapeutic effects on a variety of diseases besides cancer, including parasite infectious diseases, bacterial/fungal infections diseases, neurodegenerative diseases and autoimmune diseases. In this review, recent developments of proteasome inhibitors for various diseases and related structure activity relationships are going to be summarized.
Keywords: proteasome inhibitor, infectious diseases, autoimmune diseases, neurodegenerative diseases, drugs